UBS OCONNOR LLC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is and the CUSIP is 91381U200. A total of 37 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$429,792
-5.9%
179,0800.0%0.01%
-21.4%
Q2 2023$456,654
+31.5%
179,080
-15.9%
0.01%
+27.3%
Q1 2023$347,255213,0400.01%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 49,172$118,01314.70%
ARCH Venture Management, LLC 1,004,817$2,411,5611.57%
Mayo Clinic 124,081$297,7940.57%
Alyeska Investment Group, L.P. 1,286,000$3,086,4000.02%
UBS OCONNOR LLC 179,080$429,7920.01%
Cercano Management LLC 41,238$98,9710.00%
Johnson Midwest Financial, LLC 661$1,5860.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 50,000$120,0000.00%
Alyeska Investment Group, L.P. 38,695$92,8680.00%
Laurion Capital Management LP 70,000$168,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders